Диссертация (1140798), страница 25
Текст из файла (страница 25)
Von Knobloch // Eur. Urol. – 2002. – Vol. 41,№ 5. – P. 508-514.146167.Wade, J. Psychological impact of prostate biopsy: physical symptoms,anxiety, and depression / J. Wade // J. Clin. Oncol. – 2013. – Vol. 31, № 33. – P.4235-4241.168.Weinreb, J.C.PI-RADS prostate imaging–reporting and data system:2015, version 2 / J.C. Weinreb // Eur. Urol. – 2016. – Vol. 69, № 1. – P. 16-40.169.Weldring, T.
Patient-reported outcomes (PROs) and patient-reportedoutcome measures (PROMs) / T. Weldring, S.M.S. Smith // Health Serv. Insights.– 2013. – Vol. 6. – P. 61.170.Wang, F.B. Prostate cancer antigen 3 moderately improves diagnosticaccuracy in Chinese patients undergoing first prostate biopsy / F.B. Wang //Asian J Androl. – 2017.
– Vol. 19. – P. 238–243171.Wu, C.L. Effect of local anesthetics on patient recovery after transrectalbiopsy / C.L. Wu // Urology. – 2001. – Vol. 57, № 5. – P. 925-929.172.Xu, S. Real-time MRI-TRUS fusion for guidance of targeted prostatebiopsies / S. Xu // Comp. Aided Surg. – 2008. – Vol. 13, № 5. – P. 255-264.173.Yilmaz, A.H. Comparison of the Effect of Lidocaine versus a Lidocaine-Bupivacaine Combination in a Periprostatic Nerve Block Undergoing TransrectalUltrasound-Guided Prostate Biopsy: A Double-Blind Randomized ControlledTrial / A.H.
Yilmaz // Curr. Urol. – 2015. – Vol. 9, № 3. – P. 153-158.174.Yurdakul, T. Topical and long-acting local anesthetic for prostate biopsy: aprospective randomized placebo-controlled study / T. Yurdakul // Urol. Intern. –2009. – Vol. 83, № 2. – P. 151-154.175.Zaytoun, O.M.Morbidity of prostate biopsy after simplified versuscomplex preparation protocols: assessment of risk factors / O.M. Zaytoun //Urology. – 2011. – Vol. 77, № 4. – P. 910-914.176.Zhang, Q. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis ofprostate cancer: a single-center prospective study in China / Q. Zhang // Int. Urol.Nephrol.
– 2017. – Vol. 49, № 3. – P. 439-448.147177.Zhao, J. Risk assessment models to evaluate the necessity of prostatebiopsies in North Chinese patients with 4-50 ng/mL PSA / J. Zhao // Oncotarget.– 2016. – Vol. 5.178.Zlotta, A.R. An artificial neural network for prostate cancer staging whenserum prostate specific antigen is 10 ng./ml. or less / A.R. Zlotta // Eur. Urol. –2003.
– Vol. 169, № 5. – P. 1724-1728..















